Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)
Therapeutic Category
Cold and Cough, General and OTC medicines, Pulmonary, Respiratory, Pediatrics, Asthma
Dosage Form
Drop
Packaging Type
with Carton and Dropper
Packaging
15 ml
Price
₹87/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cufsniff LS Drop combines Ambroxol (7.5mg), Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.
This formulation is particularly beneficial for managing respiratory conditions like asthma, bronchitis, and chronic obstructive pulmonary disease (COPD), especially when they involve excessive mucus or difficulty in breathing. It provides symptomatic relief by addressing the underlying causes of respiratory discomfort, making it an essential therapy for both acute and chronic respiratory ailments. The liquid drop form is especially convenient for pediatric use, allowing accurate dosing and faster absorption.
Common side effects may include nausea, vomiting, or a mild headache. Rarely, it may cause drowsiness, dizziness, or mild gastrointestinal discomfort.
Cufsniff LS Drop is indicated for managing wet cough, bronchitis, asthma, and other respiratory conditions associated with mucus production and airway obstruction.
Do not use this medication if allergic to any of its components. Follow the prescribed dosage to avoid side effects and ensure effectiveness.
Store in a cool, dry place away from direct sunlight. Ensure the bottle is tightly closed after use and keep it out of reach of children.
Composition : Amoxycillin (80mg) + Clavulanic Acid (11.4mg) Drops
Composition : Cefixime (25mg) Drop
Composition : Cefpodoxime Proxetil (25mg)
Composition : Cephalexin (100mg) Suspension
Composition : Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (2.5mg)
Composition : Chlorpheniramine Maleate (2mg) + Phenylephrine (5mg) (Banned)
Composition : Cholecalciferol 800 I.U Drop
Composition : Cyproheptadine (1.5mg) + Tricholine Citrate (55mg)
Composition : Dicyclomine (10mg) + Dimethicone (40mg)
Composition : Dill Oil (0.005ml) + Fennel Oil (0.0007ml) + Simethicone (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Drops have strong demand in the pediatric respiratory care and cough management segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on pediatric and respiratory healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for respiratory and cough management under medical supervision. Ambroxol 7.5mg acts as a mucolytic, helping to thin and loosen mucus in the airways Levosalbutamol 0.25mg is a bronchodilator that helps relax airway muscles and improve breathing Guaifenesin 12.5mg is an expectorant that helps clear mucus from the respiratory tract Commonly prescribed for productive cough, bronchitis, respiratory congestion, and other airway conditions in pediatric patients Drop formulation ensures easy administration and improved compliance in infants and young children This strengthens a comprehensive pediatric respiratory care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ambroxol + Levosalbutamol + Guaifenesin Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong seasonal and year-round demand in pediatric practice, high prescription volume, repeat purchases, reliable supply chain support, and attractive margins in the respiratory care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.